12–13 June, 2024 in Copenhagen Denmark.
First come, first served, the application deadline was 6 May.
Participants: Assist., Assoc. and full professors, group leaders, clinicians, research coordinators from any public university or hospital from Sweden, Denmark, and Norway.
Maximum capacity: 20 participants from all partner countries (SE, NO, DK) will be accepted.
Admission: Based on CV.
Program: TBA. You can find the program from 2022 here on the webpage of the University of Copenhagen.
Costs: The course is free of cost and all expenses for travel, food, and accommodation are covered by the programme. We reimburse travel expenses up to 2,000 DKK.
Learning outcomes
- Commercialization of research-based inventions. What, how and why? Including highlighting some of the IPR differences between countries.
- Balancing basic research, commercialization and clinical trials.
- The secrets of the perfect pitch.
- Introduction to business modelling and team-work / How to formulate business models based on your research idea.
- Business Model Canvas.
Jeff Skinner, an expert in entrepreneurship and innovation from London Business School, will do a half day seminar with a relevant case based on real biomedical technologies - to explore and illustrate the role that researchers play in leading new ‘medtech’ ventures.
There will also be a groupwork session, where you will get a chance to identify the commercial potential in your research.
The course happens on an annual basis.
For further inquiries, contact:
Bjarte Reve, project manager for School of Health Innovation (SHI) bjarte.reve@medisin.uio.no
About the School of Health Innovation (SHI)
A collaboration between:
- The University of Oslo (UiO)
- Norwegian University of Science and Technology (NTNU)
- Karolinska Institutet (KI) in Stockholm
- University of Copenhagen (KU)